Drug Device Combination Products Market Size, Share, Trends, Industry Analysis Report, By Type, Application, End user, and Region- Market Forecast, 2025

Description

List of Tables

The global drug device combination products market size is expected to reach USD 343.59 billion by 2034, according to a new study by Polaris Market Research. The report "Drug Device Combination Products Market Size, Share, Trends, Industry Analysis Report, By Type (Drug Eluting Stents, Infusion Pumps, Inhalers, Orthopedic Combination Products, Wound Care Combination Products, Photodynamic Therapy Devices, Transdermal Patches, Antimicrobial Catheters, and Others), Application, End user, and Region-Market Forecast, 2023 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The rising geriatric population across the globe is driving the global drug device combination products market. Elderly individuals commonly have several chronic ailments like diabetes, hypertension, and arthritis. Drug-device combination products that combine medication delivery with monitoring or other supportive functions are especially advantageous for addressing these intricate health requirements, thus increasing the need. Thus, the growing geriatric population is expanding the market. For instance,

According to a report published by the United Nations, the number of people aged 65 years or older worldwide is projected to more than double, rising from 761 million in 2021 to 1.6 billion in 2050.

The global market for drug-device combination products is being fueled by the rising incidence of diabetes. Managing diabetes involves continuous medication and monitoring. Drug-device combination products, like insulin pumps or continuous glucose monitors (CGMs), streamline diabetes management by integrating drug delivery and monitoring into one device, increasing convenience for the patient and thereby boosting demand.

The rising investments in drug delivery activities are propelling the global drug device combination products market. Companies in the market are able to create products that cater to specific medical needs and deliver better performance than current solutions with increased investment. This drives the need for more advanced and up-to-date drug delivery devices.

Drug Device Combination Products Market Report Highlights

The transdermal patches segment dominated the market share in 2024 due to their non-invasive nature, which aligns with the rising demand for minimally invasive and patient-friendly drug delivery solutions.

Drug eluting stents segment is anticipated to witness the highest growth over the study period, due to their effectiveness in treating coronary artery disease by releasing medications that prevent restenosis of the artery.

Cardiovascular disorders segment accounted for the largest market share in 2024, owing to the critical need for advanced technologies for managing coronary artery disease and heart failure.

North America dominated the market in 2024 due to the advanced healthcare infrastructure, high levels of research and development activity, and strong regulatory frameworks that support innovation and market entry. Additionally, the presence of numerous leading pharmaceutical and medical device companies contributed to the segment's dominance.

Asia Pacific is projected to register the fastest growth over the study period, attributable to the expanding healthcare sector, increasing investments in medical technology, and rising patient populations.

The global players include Abbott; Becton, Dickinson and Company; Boston Scientific Corporation; Medtronic; Novartis AG; Sensely, Inc.; Stryker; Teleflex Incorporated; Terumo Medical Corporation; Viatris Inc.; and Hovione.

Polaris Market Research has segmented the drug device combination products market report based on type, application, End user, and region.

By Type Outlook (Revenue - USD Billion, 2020 - 2034)

Drug Eluting Stents
Infusion Pumps
Inhalers
Orthopedic Combination Products
Wound Care Combination Products
Photodynamic Therapy Devices
Transdermal Patches
Antimicrobial Catheters
Others

By Application Outlook (Revenue - USD Billion, 2020 - 2034)

Cardiovascular Disorder
Diabetes
Respiratory Problems
Cancer Treatment
Others

By End user Outlook (Revenue - USD Billion, 2020 - 2034)

Hospitals
Ambulatory Surgical Centers
Others

By Regional Outlook (Revenue - USD Billion, 2020 - 2034)

North America
US
Canada
Europe
Germany
UK
France
Italy
Spain
Russia
Netherlands
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Indonesia
Malaysia
Australia
Rest of Asia Pacific
Latin America
Argentina
Brazil
Mexico
Rest of Latin America
Middle East & Africa
UAE
Saudi Arabia
Israel
South Africa
Rest of Middle East & Africa

Product Code: PM5167

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources

4. Global Drug Device Combination Products Market Insights

4.1. Drug Device Combination Products Market - Market Snapshot
4.2. Drug Device Combination Products Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Increasing prevalence of diabetes is driving the market.
  - 4.2.1.2. Growing geriatric population worldwide propels the market.
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. Complex regulatory environment is hindering the drug device combination products market growth
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Drug Device Combination Products Market Trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis

5. Global Drug Device Combination Products Market, by Type

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
5.3. Drug Eluting Stents
- 5.3.1. Global Drug Device Combination Products Market, by Drug Eluting Stents, by Region, 2020-2034 (USD Billion)
5.4. Infusion Pumps
- 5.4.1. Global Drug Device Combination Products Market, by Infusion Pumps, by Region, 2020-2034 (USD Billion)
5.5. Inhalers
- 5.5.1. Global Drug Device Combination Products Market, by Inhalers, by Region, 2020-2034 (USD Billion)
5.6. Orthopedic Combination Products
- 5.6.1. Global Drug Device Combination Products Market, by Orthopedic Combination Products, by Region, 2020-2034 (USD Billion)
5.7. Wound Care Combination Products
- 5.7.1. Global Drug Device Combination Products Market, by Wound Care Combination Products, by Region, 2020-2034 (USD Billion)
5.8. Photodynamic Therapy Device
- 5.8.1. Global Drug Device Combination Products Market, by Photodynamic Therapy Device, by Region, 2020-2034 (USD Billion)
5.9. Transdermal Patches
- 5.9.1. Global Drug Device Combination Products Market, by Transdermal Patches, by Region, 2020-2034 (USD Billion)
5.10. Antimicrobial Catheters
- 5.10.1. Global Drug Device Combination Products Market, by Antimicrobial Catheters, by Region, 2020-2034 (USD Billion)
5.11. Other
- 5.11.1. Global Drug Device Combination Products Market, by Other, by Region, 2020-2034 (USD Billion)

6. Global Drug Device Combination Products Market, by Application

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
6.3. Cardiovascular Disorder
- 6.3.1. Global Drug Device Combination Products Market, by Cardiovascular Disorder, by Region, 2020-2034 (USD Billion)
6.4. Diabetes
- 6.4.1. Global Drug Device Combination Products Market, by Diabetes, by Region, 2020-2034 (USD Billion)
6.5. Respiratory Problems
- 6.5.1. Global Drug Device Combination Products Market, by Respiratory Problems, by Region, 2020-2034 (USD Billion)
6.6. Cancer Treatment
- 6.6.1. Global Drug Device Combination Products Market, by Cancer Treatment, by Region, 2020-2034 (USD Billion)
6.7. Other
- 6.7.1. Global Drug Device Combination Products Market, by Other, by Region, 2020-2034 (USD Billion)

7. Global Drug Device Combination Products Market, by End-user

7.1. Key Findings
7.2. Introduction
- 7.2.1. Global Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
7.3. Hospitals
- 7.3.1. Global Drug Device Combination Products Market, by Hospitals, by Region, 2020-2034 (USD Billion)
7.4. Ambulatory Surgical Centers
- 7.4.1. Global Drug Device Combination Products Market, by Ambulatory Surgical Centers, by Region, 2020-2034 (USD Billion)
7.5. Others
- 7.5.1. Global Drug Device Combination Products Market, by Others, by Region, 2020-2034 (USD Billion)

8. Global Drug Device Combination Products Market, by Geography

8.1. Key Findings
8.2. Introduction
- 8.2.1. Drug Device Combination Products Market Assessment, By Geography, 2020-2034 (USD Billion)
8.3. Drug Device Combination Products Market - North America
- 8.3.1. North America: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
- 8.3.2. North America: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
- 8.3.3. North America: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
- 8.3.4. Drug Device Combination Products Market - U.S.
  - 8.3.4.1. U.S.: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  - 8.3.4.2. U.S.: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  - 8.3.4.3. U.S.: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
- 8.3.5. Drug Device Combination Products Market - Canada
  - 8.3.5.1. Canada: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  - 8.3.5.2. Canada: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  - 8.3.5.3. Canada: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
8.4. Drug Device Combination Products Market - Europe
- 8.4.1. Europe: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
- 8.4.2. Europe: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
- 8.4.3. Europe: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
- 8.4.4. Drug Device Combination Products Market - UK
  - 8.4.4.1. UK: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  - 8.4.4.2. UK: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  - 8.4.4.3. UK: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
- 8.4.5. Drug Device Combination Products Market - France
  - 8.4.5.1. France: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  - 8.4.5.2. France: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  - 8.4.5.3. France: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
- 8.4.6. Drug Device Combination Products Market - Germany
  - 8.4.6.1. Germany: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  - 8.4.6.2. Germany: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  - 8.4.6.3. Germany: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
- 8.4.7. Drug Device Combination Products Market - Italy
  - 8.4.7.1. Italy: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  - 8.4.7.2. Italy: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  - 8.4.7.3. Italy: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
- 8.4.8. Drug Device Combination Products Market - Spain
  - 8.4.8.1. Spain: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  - 8.4.8.2. Spain: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  - 8.4.8.3. Spain: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
- 8.4.9. Drug Device Combination Products Market - Netherlands
  - 8.4.9.1. Netherlands: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  - 8.4.9.2. Netherlands: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  - 8.4.9.3. Netherlands: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
- 8.4.10. Drug Device Combination Products Market - Russia
  - 8.4.10.1. Russia: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  - 8.4.10.2. Russia: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  - 8.4.10.3. Russia: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
- 8.4.11. Drug Device Combination Products Market - Rest of Europe
  - 8.4.11.1. Rest of Europe: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  - 8.4.11.2. Rest of Europe: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  - 8.4.11.3. Rest of Europe: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
8.5. Drug Device Combination Products Market - Asia Pacific
- 8.5.1. Asia Pacific: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
- 8.5.2. Asia Pacific: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
- 8.5.3. Asia Pacific: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
- 8.5.4. Drug Device Combination Products Market - China
  - 8.5.4.1. China: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  - 8.5.4.2. China: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  - 8.5.4.3. China: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
- 8.5.5. Drug Device Combination Products Market - India
  - 8.5.5.1. India: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  - 8.5.5.2. India: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  - 8.5.5.3. India: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
- 8.5.6. Drug Device Combination Products Market - Malaysia
  - 8.5.6.1. Malaysia: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  - 8.5.6.2. Malaysia: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  - 8.5.6.3. Malaysia: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
- 8.5.7. Drug Device Combination Products Market - Japan
  - 8.5.7.1. Japan: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  - 8.5.7.2. Japan: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  - 8.5.7.3. Japan: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
- 8.5.8. Drug Device Combination Products Market - Indonesia
  - 8.5.8.1. Indonesia: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  - 8.5.8.2. Indonesia: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  - 8.5.8.3. Indonesia: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
- 8.5.9. Drug Device Combination Products Market - South Korea
  - 8.5.9.1. South Korea: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  - 8.5.9.2. South Korea: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  - 8.5.9.3. South Korea: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
- 8.5.10. Drug Device Combination Products Market - Australia
  - 8.5.10.1. Australia: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  - 8.5.10.2. Australia: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  - 8.5.10.3. Australia: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
- 8.5.11. Drug Device Combination Products Market - Rest of Asia Pacific
  - 8.5.11.1. Rest of Asia Pacific: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  - 8.5.11.2. Rest of Asia Pacific: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  - 8.5.11.3. Rest of Asia Pacific: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
8.6. Drug Device Combination Products Market - Middle East & Africa
- 8.6.1. Middle East & Africa: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
- 8.6.2. Middle East & Africa: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
- 8.6.3. Middle East & Africa: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
- 8.6.4. Drug Device Combination Products Market - Saudi Arabia
  - 8.6.4.1. Saudi Arabia: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  - 8.6.4.2. Saudi Arabia: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  - 8.6.4.3. Saudi Arabia: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
- 8.6.5. Drug Device Combination Products Market - UAE
  - 8.6.5.1. UAE: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  - 8.6.5.2. UAE: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  - 8.6.5.3. UAE: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
- 8.6.6. Drug Device Combination Products Market - Israel
  - 8.6.6.1. Israel: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  - 8.6.6.2. Israel: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  - 8.6.6.3. Israel: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
- 8.6.7. Drug Device Combination Products Market - South Africa
  - 8.6.7.1. South Africa: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  - 8.6.7.2. South Africa: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  - 8.6.7.3. South Africa: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
- 8.6.8. Drug Device Combination Products Market - Rest of Middle East & Africa
  - 8.6.8.1. Rest of Middle East & Africa: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  - 8.6.8.2. Rest of Middle East & Africa: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  - 8.6.8.3. Rest of Middle East & Africa: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
8.7. Drug Device Combination Products Market - Latin America
- 8.7.1. Latin America: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
- 8.7.2. Latin America: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
- 8.7.3. Latin America: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
- 8.7.4. Drug Device Combination Products Market - Mexico
  - 8.7.4.1. Mexico: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  - 8.7.4.2. Mexico: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  - 8.7.4.3. Mexico: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
- 8.7.5. Drug Device Combination Products Market - Brazil
  - 8.7.5.1. Brazil: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  - 8.7.5.2. Brazil: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  - 8.7.5.3. Brazil: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
- 8.7.6. Drug Device Combination Products Market - Argentina
  - 8.7.6.1. Argentina: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  - 8.7.6.2. Argentina: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  - 8.7.6.3. Argentina: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
- 8.7.7. Drug Device Combination Products Market - Rest of Latin America
  - 8.7.7.1. Rest of Latin America: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  - 8.7.7.2. Rest of Latin America: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  - 8.7.7.3. Rest of Latin America: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)

9. Competitive Landscape

9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

10.1. Abbott
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
10.2. Becton, Dickinson and Company
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
10.3. Boston Scientific Corporation
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
10.4. Medtronic
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
10.5. Novartis AG
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
10.6. Sensely, Inc.
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
10.7. Stryker
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
10.8. Teleflex Incorporated
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
10.9. Terumo Medical Corporation
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
10.10. Viatris Inc.
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.10.4. Recent Development
10.11. Hovione
- 10.11.1. Company Overview
- 10.11.2. Financial Performance
- 10.11.3. Product Benchmarking
- 10.11.4. Recent Development